Literature DB >> 3667750

Quantitative analysis of sterols in serum by high-performance liquid chromatography. Application to the biochemical diagnosis of cerebrotendinous xanthomatosis.

T Kasama1, D S Byun, Y Seyama.   

Abstract

A method for the simultaneous determination of 5 alpha-cholestan-3 beta-ol and cholesterol in serum by high-performance liquid chromatography was developed. After addition of internal standard (5 beta-cholestan-3 alpha-ol) and saponification with ethanolic potassium hydroxide, the sterols were converted into their benzoyl derivatives, which were subjected to reversed-phase liquid chromatography with ultraviolet detection at 228 nm. Only 0.1 ml of serum was needed to give a reproducible result. This method has been used for the biochemical diagnosis of cerebrotendinous xanthomatosis, a hereditary disorder of cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667750     DOI: 10.1016/s0021-9673(01)81617-4

Source DB:  PubMed          Journal:  J Chromatogr


  6 in total

1.  Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27).

Authors:  S Sugama; A Kimura; W Chen; S Kubota; Y Seyama; N Taira; Y Eto
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

2.  Epicoprostanol found in adipocere from five human autopsies.

Authors:  J Adachi; Y Ueno; A Miwa; M Asano; A Nishimura; Y Tatsuno
Journal:  Lipids       Date:  1997-11       Impact factor: 1.880

3.  Genetic analysis of phytosterolaemia.

Authors:  M Togo; T Toda; L A Nguyen; S Kubota; K Tsukamoto; H Satoh; M Hara; N Iso-o; H Noto; S Kimura; K Nakahara; Y Seyama; Y Hashimoto
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

4.  Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients.

Authors:  Y Hokezu; M Kuriyama; R Kubota; M Nakagawa; J Fujiyama; M Osame
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

5.  Electrophysiological studies in cerebrotendinous xanthomatosis.

Authors:  Y Tokimura; M Kuriyama; K Arimura; J Fujiyama; M Osame
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

6.  Pharmacometabolomic signature of ataxia SCA1 mouse model and lithium effects.

Authors:  Bertrand Perroud; Paymaan Jafar-Nejad; William R Wikoff; Jennifer R Gatchel; Lu Wang; Dinesh K Barupal; Juan Crespo-Barreto; Oliver Fiehn; Huda Y Zoghbi; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.